08/08/2024
4:16 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
4:18 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
4:40 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
9:51 AM | Neurocrine Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/01/2024
6:03 AM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
6:04 AM | Neurocrine Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/18/2024
3:54 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
07/18/2024
4:00 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
4:12 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
3:45 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
3:41 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:28 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
3:29 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
3:29 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
3:30 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
3:37 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024
8:36 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
8:09 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
3:38 PM | Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:51 PM | Neurocrine Biosciences (Issuer)
RASTETTER WILLIAM H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:45 PM | Neurocrine Biosciences (Issuer)
POON CHRISTINE A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
4:59 PM | Mercier Johanna (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:02 PM | Neurocrine Biosciences (Issuer)
Norwalk Leslie V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:17 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:21 PM | MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:26 PM | Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:29 PM | Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:34 PM | Neurocrine Biosciences (Issuer)
Sharp Shalini (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:27 PM | Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:35 PM | Neurocrine Biosciences (Issuer)
Sharp Shalini (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:15 PM | MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:57 PM | LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:06 PM | Neurocrine Biosciences (Issuer)
Norwalk Leslie V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:51 PM | Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:46 PM | Mercier Johanna (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
3:31 PM | Neurocrine Biosciences (Subject)
Norwalk Leslie V (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024
3:31 PM | Neurocrine Biosciences (Subject)
Sharp Shalini (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024
3:32 PM | Neurocrine Biosciences (Subject)
POPS RICHARD F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
3:40 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
3:23 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024
3:26 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Why Apple’s Stock Could Be a Recession Safe Zone (Ad) The iPhone has been Apple's #1 product for over a decade…
But it may not even exist as we know it by September 10. Here's Why |
05/01/2024
6:01 AM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
6:03 AM | Neurocrine Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/17/2024
4:19 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
3:29 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:40 PM | Neurocrine Biosciences (Filer)
| Form ARS | |
04/10/2024
3:31 PM | Neurocrine Biosciences (Filer)
| Form DEFA14A | |
04/10/2024
3:07 PM | Neurocrine Biosciences (Filer)
| Form DEF 14A | |
04/03/2024
3:44 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
5:02 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:20 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
4:25 PM | MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:33 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:15 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
4:19 PM | Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
3:32 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024
3:33 PM | MORROW GEORGE J (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024
5:47 PM | Neurocrine Biosciences (Issuer)
Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
5:38 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
3:22 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:22 PM | Neurocrine Biosciences (Subject)
POPS RICHARD F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
5:55 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
6:02 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
5:50 PM | Neurocrine Biosciences (Issuer)
Norwalk Leslie V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
4:11 PM | Neurocrine Biosciences (Issuer)
POPS RICHARD F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:51 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:40 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:43 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:45 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:48 PM | Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:27 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:29 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:33 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:35 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
4:38 PM | Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
4:17 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
3:18 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
3:19 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
3:19 PM | Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
3:20 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
3:20 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
4:29 PM | Neurocrine Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/08/2024
6:46 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:35 PM | Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:21 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:25 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:28 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:12 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:15 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
6:17 PM | Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:21 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
US developing “war ending superweapon”? (Ad) What’s driving this military investment opportunity? For the first time in history, 3 “wealth factors” are converging now to create a perfect storm for investors. Go here to see everything you need. |
02/08/2024
3:21 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024
6:00 AM | Neurocrine Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
6:21 PM | GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:24 PM | Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:26 PM | Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:29 PM | Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:00 PM | ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:05 PM | BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:07 PM | Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
